Research Article
Incidence and Impact of Ventilator Associated Multidrug Resistant Pneumonia in Patients with SARS-COV2
Table 3
Frequency of VAP organisms and MDROs.
| VAP species | Count | MDRO |
| Staphylococcus aureus | 14 (28%) | 6 (12%) | Klebsiella spp | 10 (20%) | 2 (4%) | Pseudomonas spp | 8 (16%) | 8 (16%) | Escherichia coli | 4 (8%) | 1 (2%) | Stentrophomonas maltophilia | 2 (4%) | 2 (4%) | Serratia spp | 2 (4%) | 1 (2%) | Haemophilus influenzae | 2 (4%) | | Moraxella catarrhalis | 2 (4%) | | Citrobacter spp | 2 (4%) | | Enterobacter spp | 1 (2%) | | Streptococcus pneumoniae | 2 (4%) | | Streptococcus agalactiae | 1 (2%) | | Total | 50 | 20 (40%) |
|
|
VAP–ventilator associated pneumonia; MDRO–multi-drug resistant organism; Spp–species.
|